Catalyst Pharmaceuticals Inc (CPRX) — Free Cash Flow Generation Index
Catalyst Pharmaceuticals Inc (CPRX) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of $44.86 Million represents 1% of operating cash flow ($44.89 Million). See how liquid is Catalyst Pharmaceuticals Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Catalyst Pharmaceuticals Inc Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Catalyst Pharmaceuticals Inc across 7 annual periods. Explore Catalyst Pharmaceuticals Inc (CPRX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Catalyst Pharmaceuticals Inc (2019–2025)
Year-by-year Free Cash Flow Generation Index for Catalyst Pharmaceuticals Inc. For the full company profile including market capitalisation, see CPRX market cap.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $208.61 Million | $208.67 Million | $58.00K | ▲ +0.2% |
| 2024 | 1.00x | $239.25 Million | $239.81 Million | $556.00K | ▲ +131.6% |
| 2023 | 0.43x | $61.86 Million | $143.60 Million | $81.74 Million | ▼ -56.9% |
| 2022 | 1.00x | $116.02 Million | $116.05 Million | $29.00K | ▲ +1.7% |
| 2021 | 0.98x | $59.35 Million | $60.37 Million | $1.02 Million | ▼ -1.7% |
| 2020 | 1.00x | $45.02 Million | $45.03 Million | $11.39K | ▲ +0.0% |
| 2019 | 1.00x | $34.59 Million | $34.61 Million | $19.37K | — |